Methacholine and histamine challenge Source: Annual Congress 2010 - PG10 Postgraduate Course: Bronchial challenge tests: usefulness, availability and limitations Year: 2010
Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma Source: Eur Respir J 2004; 23: 714-717 Year: 2004
Bronchial hyperresponsiveness to methacholine/AMP and the bronchodilator response in asthmatic children Source: Eur Respir J 2011; 37: 800-805 Year: 2011
Protection by formoterol and salmeterol on bronchoconstriction provoked by methacholine and AMP in asthmatics Source: Eur Respir J 2002; 20: Suppl. 38, 307s Year: 2002
Methacholine challenge test in allergic rhinitis patients Source: Eur Respir J 2005; 26: Suppl. 49, 130s Year: 2005
Bronchial hyperresponsiveness to adenosine 5‘-monophosphate and methacoline: a comparison trial Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007
Methacholine challenge testing with a single low methacholine concentration Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment Year: 2009
Protection against methacholine-induced bronchospasm: salbutamol pMDI versus Clickhaler(R) DPI Source: Eur Respir J 2003; 21: 816-820 Year: 2003
Airway responsiveness to methacholine and deep inhalations in rhinitic subjects Source: Eur Respir J 2006; 28: Suppl. 50, 218s Year: 2006
Protective effect of inhaled anticholinergic drugs in the methacholine test Source: Eur Respir J 2007; 30: Suppl. 51, 619s Year: 2007
Can the interrupter resistance be used to measure airway hyperresponsiveness during the methacholine challenge test as a substitute for FEV1? Source: Virtual Congress 2021 – New insights into lung function testing Year: 2021
Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009
Comparison of the bronchoprotective effects of two salbutamol suplphate HFA pMDI using methacholine challenge testing Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II Year: 2011
Effects on bronchial response to methacholine of BDP-HFA and BDP-CFC Source: Eur Respir J 2003; 22: Suppl. 45, 476s Year: 2003
Bronchospasm secondary to nebulised antibiotics in bronchiectasis Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017
Bronchial hypersensitivity and acute bronchodilatory effect of salbutamol on methacholine-induced bronchoconstriction in asthmatics with excessive airway narrowing Source: Eur Respir J 2004; 24: Suppl. 48, 442s Year: 2004
Airway hyperresponsiveness in children Source: Eur Respir Mon 2012; 56: 158-171 Year: 2012
Bronchoconstriction induced by inhaled adenosine 5'-monophosphate in subjects with allergic rhinitis Source: Eur Respir J 2001; 17: 64-70 Year: 2001
Long-term macrolide therapy in chronic inflammatory airway diseases Source: Eur Respir J 2009; 33: 171-181 Year: 2009
Agreement of dosimetric histamine and metacholine tests for assessment of bronchial hyperresponsiveness Source: Eur Respir J 2007; 30: Suppl. 51, 618s Year: 2007